Establish and convey the value of sustained investment for developing coronavirus vaccines.
Value case for vaccines
Communication tools
Financial models meeting
Long-term investment
Reassess the current landscape of intellectual property rights to improve information sharing involving new technologies.
Publicly funded research
Patent and licensure access
Expand equitable, high quality, and sustainable global manufacturing capacity relevant to coronavirus vaccines and pandemic preparedness.
Equitable manufacturing distribution
Platform transfer